European Journal of Cancer
Volume 46, Issue 1 , Pages 102-109, January 2010

Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer

  • C.G. Gerestein

      Affiliations

    • Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Daniel Den Hoed/Erasmus MC University Medical Center, Rotterdam, The Netherlands
    • Department of Obstetrics and Gynecology, Albert Schweitzer Hospital, Dordrecht, The Netherlands
    • Corresponding Author InformationCorresponding author: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Erasmus MC/Daniel Den Hoed University Oncology Center, Groene Hilledijk 301, 3075 AE Rotterdam, The Netherlands. Tel.: +31 10 7041263; fax: +31 10 4391986.
    • ,
  • G.M. Nieuwenhuyzen-de Boer

      Affiliations

    • Department of Obstetrics and Gynecology, Albert Schweitzer Hospital, Dordrecht, The Netherlands
    • ,
  • M.J. Eijkemans

      Affiliations

    • Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    • ,
  • G.S. Kooi

      Affiliations

    • Department of Obstetrics and Gynecology, Albert Schweitzer Hospital, Dordrecht, The Netherlands
    • ,
  • C.W. Burger

      Affiliations

    • Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Daniel Den Hoed/Erasmus MC University Medical Center, Rotterdam, The Netherlands

Received 19 June 2009; received in revised form 8 October 2009; accepted 15 October 2009. published online 09 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(09)00775-8

doi:10.1016/j.ejca.2009.10.017

European Journal of Cancer
Volume 46, Issue 1 , Pages 102-109, January 2010

Article Tools

* Image Usage & Resolution